Swellable hydrophilic matrix tablets for oral drug delivery: Mechanisms, polymer systems, formulation design and future directions

Swellable hydrophilic matrix tablets represent one of the most extensively validated platforms for oral controlled drug delivery, with a track record spanning several decades of clinical and commercial application. The mechanism by which these systems operate is, in principle, straightforward: upon contact with gastrointestinal fluid, the polymer at the tablet surface hydrates, undergoes a glassy-to-rubbery phase transition, and forms a gel layer that envelops the core. The properties of this gel layer — its thickness, its viscosity, and its resistance to erosion — govern the rate at which drug molecules diffuse outward and, consequently, the overall release profile. A formulation in which the gel layer is appropriately characterised is one in which the release kinetics largely take care of themselves; conversely, deficiencies at this stage are rarely correctable through subsequent formulation adjustments.
This review synthesises both foundational and contemporary literature to examine swellable matrix systems from several complementary perspectives. The discussion begins with the underlying mechanistic principles before proceeding to classification schemes, commonly employed polymers and excipients, manufacturing considerations, and the in vitro evaluation methods used during formulation development. Particular emphasis is placed on the relationship between polymer concentration and viscosity grade, a focus that reflects both its prominence in the existing literature and its status as the parameter formulators are most directly able to control. A survey of drug-specific studies across multiple therapeutic categories is also presented, illustrating the breadth of clinical application this platform has achieved. The review concludes with an examination of persistent challenges in the field — most notably, the difficulty of predicting in vivo performance from in vitro dissolution data — and identifies areas of active innovation, including gastroretentive matrix designs, hybrid natural-synthetic polymer systems, and stimuli-responsive release architectures.